Dorothy Clarke - 07 Nov 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc. (CMRA)

Role
Director
Signature
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
Issuer symbol
CMRA
Transactions as of
07 Nov 2023
Net transactions value
$0
Form type
4
Filing time
13 Nov 2023, 06:31:17 UTC
Previous filing
01 Sep 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRA Stock Option (Right to Purchase Award $0 +14,200 $0.000000 14,200 07 Nov 2023 Common Stock 14,200 $0.3550 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan. The stock option shall vest over three (3) years, with one-third of the shares of common stock underlying the option vesting on November 7, 2024, and the remainder vesting in equal monthly installments thereafter.